'Clot-busting' drugs reduce deaths from pulmonary embolism by nearly half

Adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant medications alone, a team of researchers has found, bringing clarity to a decades-long debate.

Read the whole article on Science Daily

More from Science Daily